{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:36:17Z","timestamp":1783488977026,"version":"3.55.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Technology Plan Fund from Yaan Science and Technology Bureau\u00ef\u00bc\u02c6CN\u00ef\u00bc\u2030","award":["22KJJH0039"],"award-info":[{"award-number":["22KJJH0039"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The combination of methimazole and propranolol is considered an effective treatment regimen for hyperthyroidism in clinical practice; however, detrimental effects on the heart rate, bone metabolism and thyroid hormone levels have been reported. Therefore, the present study aimed to systematically review the efficacy and safety differences in patients with hyperthyroidism and the effects of treatment on heart rate, bone metabolism, cortisol, and adrenocorticotropic hormone levels using case\u2013control studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Clinical case\u2013control trials of methimazole combined with propranolol for the treatment of hyperthyroidism were selected from Chinese and English databases, and data were collected from the establishment of the database until August 2024. Two independent researchers evaluated the quality of the literature using the Newcastle\u2013Ottawa Scale (NOS). Meta-analysis of each effect index was performed using RevMan software (version 5.3), and the quality of the results was evaluated using the GRADE profiler system letter description method.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Sixteen clinical case\u2013control trials were included in this study. Of these, 2 trials exhibited NOS scores of 7, 6 trials exhibited NOS scores of 6, and 8 trials exhibited NOS scores of 5. These accounted for 12.5% of the high-quality literatures, and included 772 patients treated with methimazole combined with propranolol (observation group) and 771 patients treated with methimazole alone (control group). The results of the meta-analysis demonstrated that methimazole combined with propranolol improved the cure rate, the total effective rate, and heart rate, compared with the control group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). In addition, calcification, bone glutamate protein, free triiodothyronine, free tetraiodothyronine, thyroid-stimulating hormone, cortisol, and adrenocorticotropic hormone were significantly different between the 2 groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). There were no significant differences in leukemia, headache, dizziness, skin pruritus, bone pain, arthralgia, or in improving parathyroid hormone or reducing gastrointestinal reactions between the 2 groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The present study demonstrated that methimazole combined with propranolol may significantly improve the heart rate, bone metabolism and associated hormone levels in patients with hyperthyroidism, without significantly increasing the risk of adverse reactions. However, due to the impact of primary literature type, quality or research methods high-quality, multicenter, rigorously designed clinical trials are required for further verification.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040495","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T20:02:29Z","timestamp":1731355349000},"page":"e40495","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The effects of methimazole combined with propranolol on heart rate, bone metabolism, and thyroid hormone levels in patients with hyperthyroidism: A systematic review and a meta-analysis of case\u2013control studies"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3055-0439","authenticated-orcid":false,"given":"Xingxing","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Yaan People\u2019s Hospital, Yaan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Xichong People\u2019s Hospital, Nanchong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fan","sequence":"additional","affiliation":[{"name":"Clinical Trial Center for Drugs and Medical Devices, Yaan People\u2019s Hospital, Yaan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yaan People\u2019s Hospital, Yaan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Drug Clinical Trial Institute, Affiliated Hospital of Southwest Medical University, Luzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yaan People\u2019s Hospital, Yaan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1021\/acsomega.2c08048","article-title":"Serum lipidomic analysis reveals biomarkers and metabolic pathways of thyroid dysfunction.","volume":"8","author":"Dong","year":"2023","journal-title":"ACS Omega"},{"key":"R2-20250504","first-page":"255","article-title":"Hyperthyroidism and cardiovascular risk factors: a nationwide study.","volume":"70","author":"Iglesias","year":"2023","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1089\/thy.2021.0544","article-title":"The prevalence of thyroid dysfunction in korean women undergoing routine health screening: a cross-sectional study.","volume":"32","author":"Kim","year":"2022","journal-title":"Thyroid"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/13697137.2018.1514004","article-title":"Thyroid disease in the perimenopause and postmenopause period.","volume":"21","author":"Uygur","year":"2018","journal-title":"Climacteric"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/aam.aam_105_22","article-title":"Association between hyperthyroidism and thromboembolism: a retrospective observational study.","volume":"22","author":"Alsaidan","year":"2023","journal-title":"Ann Afr Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/cells12060918","article-title":"Molecular mechanisms in autoimmune thyroid disease.","volume":"12","author":"Vargas-Uricoechea","year":"2023","journal-title":"Cells"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.3390\/jcm12062234","article-title":"Insights on the association between thyroid diseases and colorectal cancer.","volume":"12","author":"Gagliardi","year":"2023","journal-title":"J Clin Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1089\/thy.2019.0180","article-title":"Increased remission rates after long-term methimazole therapy in patients with Graves\u2019 disease: results of a randomized clinical trial.","volume":"29","author":"Azizi","year":"2019","journal-title":"Thyroid"},{"key":"R9-20250504","first-page":"2366","article-title":"Literature analysis of 30 cases of insulin autoimmune syndrome induced by methimazole.","volume":"37","author":"Xie","year":"2022","journal-title":"Mod Med Clin"},{"key":"R10-20250504","first-page":"1894","article-title":"Literature analysis of 24 cases of methimazole-induced cholestatic liver injury.","volume":"35","author":"Xie","year":"2018","journal-title":"Chin Mod App Phar"},{"key":"R11-20250504","first-page":"876","article-title":"Chinese guidelines for diagnosis and treatment of thyroid diseases: hyperthyroidism.","volume":"46","year":"2007","journal-title":"Chin J Int Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.","volume":"4","author":"Tkins","year":"2004","journal-title":"BMC Health Serv Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1472-6963-5-25","article-title":"Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system.","volume":"5","author":"Atkins","year":"2005","journal-title":"BMC Health Serv Res"},{"key":"R17-20250504","first-page":"90","article-title":"Effects of propranolol combined with methimazole on improvement of heart rate and changes of serum FT-3, TSH and FT-4 levels in patients with hyperthyroidism.","volume":"15","author":"Yun","year":"2018","journal-title":"J Chin Med"},{"key":"R18-20250504","first-page":"1963","article-title":"Effects of propranolol combined with methimazole on calcium and phosphorus metabolism, glucose and lipid metabolism, serum CysC, COR and ACTH levels in patients with hyperthyroidism.","volume":"20","author":"Yu","year":"2021","journal-title":"J Clin Exp Med"},{"key":"R19-20250504","first-page":"816","article-title":"Effect of propranolol combined with methimazole on serum cortisol and adrenocorticotropin levels in children with hyperthyroidism.","volume":"36","author":"Tang","year":"2021","journal-title":"Chin Mat Child Health Care"},{"key":"R20-20250504","first-page":"191","article-title":"Efficacy of methimazole combined with propranolol in the treatment of hyperthyroidism.","volume":"7","author":"Fang","year":"2017","journal-title":"Chin Med Sci"},{"key":"R21-20250504","first-page":"64","article-title":"Effect of propranolol combined with methimazole on hyperthyroidism and its effect on bone metabolism.","volume":"27","author":"Li","year":"2018","journal-title":"Chin Phar Industry"},{"key":"R22-20250504","first-page":"61","article-title":"Effect of propranolol combined with methimazole on hyperthyroidism and its effect on bone metabolism.","volume":"17","author":"Li","year":"2020","journal-title":"Nor Phar"},{"key":"R23-20250504","first-page":"378","article-title":"Clinical effect of methimazole combined with propranolol in the treatment of hyperthyroidism.","volume":"35","author":"Hong","year":"2022","journal-title":"Heilongjiang Med"},{"key":"R24-20250504","first-page":"99","article-title":"Effect of propranolol combined with methimazole on hyperthyroidism and its effect on bone metabolism.","volume":"15","author":"Pan","year":"2018","journal-title":"Chin Med Inno"},{"key":"R25-20250504","first-page":"33","article-title":"Changes of thyroid function, serum COR and ACTH levels in patients with mild to moderate hyperthyroidism treated with methimazole combined with propranolol.","volume":"32","author":"Wang","year":"2019","journal-title":"Clin Misdiagnosis treat"},{"key":"R26-20250504","first-page":"135","article-title":"Efficacy of methimazole combined with propranolol in the treatment of hyperthyroidism.","volume":"11","author":"Hu","year":"2019","journal-title":"Chin J Conti Med Edu"},{"key":"R27-20250504","first-page":"132","article-title":"Efficacy of methimazole combined with propranolol in the treatment of hyperthyroidism.","volume":"31","author":"Fan","year":"2021","journal-title":"Shenzhen J Inte Chin Western Med"},{"key":"R28-20250504","first-page":"168","article-title":"Prospective randomized controlled study of propranolol combined with methimazole in the treatment of hyperthyroidism.","volume":"19","author":"Xie","year":"2022","journal-title":"Nor Phar"},{"key":"R29-20250504","first-page":"47","article-title":"Efficacy of methimazole combined with propranolol in the treatment of hyperthyroidism.","volume":"33","author":"Guo","year":"2021","journal-title":"Chin J Med Sci"},{"key":"R30-20250504","first-page":"634","article-title":"Effects of methimazole combined with propranolol on hormone levels and long-term recurrence rate of hyperthyroidism.","volume":"37","author":"Chen","year":"2019","journal-title":"Huaihai Phar"},{"key":"R31-20250504","first-page":"1884","article-title":"Effects of methimazole combined with propranolol on hormone levels and long-term recurrence rate of hyperthyroidism.","volume":"34","author":"Ma","year":"2021","journal-title":"Med Theo Prac"},{"key":"R32-20250504","first-page":"132","article-title":"Effect of propranolol combined with methimazole in the treatment of mild to moderate hyperthyroidism.","volume":"21","author":"Ma","year":"2023","journal-title":"Chin Fore Med Res"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e13192","DOI":"10.1111\/eci.13192","article-title":"Triiodothyronine secretion in early thyroid failure: the adaptive response of central feedforward control.","volume":"50","author":"Hoermann","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"R34-20250504","first-page":"16","article-title":"Toxic multinodular goiter in the elderly.","volume":"25","author":"Vitti","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40618-015-0391-7","article-title":"Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.","volume":"39","author":"Knobel","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/JOE-12-0204","article-title":"Iodothyronine deiodinase structure and function: from ascidians to humans.","volume":"215","author":"Darras","year":"2012","journal-title":"J Endocrinol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/clc.4960230605","article-title":"Hyperthyroid heart disease.","volume":"23","author":"adel","year":"2000","journal-title":"Clin Cardiol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1167\/iovs.10-5276","article-title":"Altered ganglioside expression modulates the pathogenic mechanism of thyroid-associated ophthalmopathy by increase in hyaluronic acid.","volume":"52","author":"Kook","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1055\/s-0042-117509","article-title":"Parathyroid hormone polymorphism RS6254 is associated with the development and severity of osteoporosis in asymptomatic but not normocalcemic hyperthyroidism.","volume":"48","author":"D\u00edaz-Soto","year":"2016","journal-title":"Horm Metab Res"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1139\/y55-038","article-title":"Distribution of adrenaline and noradrenaline in the normal and hyperthyroid rat following adrenaline administration.","volume":"33","author":"Leduc","year":"1955","journal-title":"Can J Biochem Physiol"},{"key":"R41-20250504","first-page":"496","article-title":"Changes of adrenal cortex function in patients with hyperthyroidism.","volume":"18","author":"Li","year":"2003","journal-title":"Chin J Gener Sur"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:01:36Z","timestamp":1746320496000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":40,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040495","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}